Qiagen has been awarded US Patent No. 7,829,691, "Detection of nucleic acids by type-specific hybrid capture method."
James Anthony, Attila Lorincz, John Troy, and Yanglin Tan have been named as inventors on the patent.
Describes target-specific hybrid capture, a nucleic acid detection method that is not only rapid and sensitive, but is also highly specific and capable of discriminating highly homologous nucleic acid target sequences, the patent's abstract states. The method produces DNA-RNA hybrids, which can be detected by a variety of methods.